Search by Drug Name or NDC

    NDC 49708-0754-41 BROMSITE 0.76 mg/mL Details

    BROMSITE 0.76 mg/mL

    BROMSITE is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is BROMFENAC SODIUM.

    Product Information

    NDC 49708-0754
    Product ID 49708-754_9c90e2ce-302f-4b3c-b7f8-1ab0e14b9c47
    Associated GPIs 86805005102008
    GCN Sequence Number 075891
    GCN Sequence Number Description bromfenac sodium DROPS 0.075 % OPHTHALMIC
    HIC3 Q6P
    HIC3 Description EYE ANTI-INFLAMMATORY AGENTS
    GCN 41057
    HICL Sequence Number 013633
    HICL Sequence Number Description BROMFENAC SODIUM
    Brand/Generic Brand
    Proprietary Name BROMSITE
    Proprietary Name Suffix 0.08%
    Non-Proprietary Name bromfenac
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION/ DROPS
    Route OPHTHALMIC
    Active Ingredient Strength 0.76
    Active Ingredient Units mg/mL
    Substance Name BROMFENAC SODIUM
    Labeler Name Sun Pharmaceutical Industries, Inc.
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA206911
    Listing Certified Through 2024-12-31

    Package

    NDC 49708-0754-41 (49708075441)

    NDC Package Code 49708-754-41
    Billing NDC 49708075441
    Package 1 POUCH in 1 CARTON (49708-754-41) / 1 BOTTLE, DROPPER in 1 POUCH / 5 mL in 1 BOTTLE, DROPPER
    Marketing Start Date 2016-05-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 49.7512
    Pricing Unit ML
    Effective Date 2023-12-20
    NDC Description BROMSITE 0.075% EYE DROPS
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis